Leef Brands Stock Canadian Securities Exchange
Stocks
LEEF
CA52426X1042
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2500 CAD | -3.85% |
|
-10.71% | +19.05% |
| 08-07 | Leef Brands Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Earnings Flash (LEEF.CN) LEEF Brands Inc. Reports Q2 Net Revenue $7.3M | MT |
| Market Cap | 54.81M 47.41M 44.27M 40.61M 76.39M 5.22B 77.6M 519M 204M 2.61B 206M 201M 8.64B | P/E 2024 |
-1.21x | P/E 2025 | -1.61x |
|---|---|---|---|---|---|
| Enterprise Value | 66.75M 57.74M 53.92M 49.46M 93.03M 6.35B 94.51M 633M 248M 3.18B 251M 245M 10.53B | EV / Sales 2024 |
1.97x | EV / Sales 2025 | 1.48x |
| Free-Float |
75.85% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Leef Brands
| 1 week | -10.71% | ||
| Current month | -10.71% | ||
| 1 month | -19.35% | ||
| 3 months | +11.11% | ||
| 6 months | +56.25% | ||
| Current year | +19.05% |
| 1 week | 0.24 |  | 0.29 |
| 1 month | 0.24 | | 0.31 |
| 3 years | 0.05 | | 0.41 |
| 5 years | 0.05 | | 4.15 |
| 10 years | 0.05 | | 20.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Micah Anderson
CEO | Chief Executive Officer | - | 2022-04-20 |
Kevin Wilson
DFI | Director of Finance/CFO | - | 2022-11-30 |
Joshua Keats
COO | Chief Operating Officer | - | 2025-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Micah Anderson
BRD | Director/Board Member | - | 2022-04-20 |
Kevin Wilson
BRD | Director/Board Member | - | 2024-07-25 |
Emily Heitman
BRD | Director/Board Member | - | 2022-06-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.85% | -10.71% | 0.00% | 0.00% | 54.81M | |
| +0.15% | +4.35% | +54.17% | -4.92% | 2.46B | |
| -2.78% | +1.16% | +52.71% | +107.10% | 1.68B | |
| +1.78% | +8.33% | -44.57% | +157.66% | 506M | |
| -3.85% | -10.71% | 0.00% | 0.00% | 54.81M | |
| Average | -1.18% | +0.78% | +12.46% | +51.97% | 1.18B | |
| Weighted average by Cap. | -0.77% | +3.46% | +41.90% | +52.09% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.5M 24.65M 23.02M 21.12M 39.72M 2.71B 40.35M 270M 106M 1.36B 107M 105M 4.49B | 34.79M 30.09M 28.1M 25.78M 48.49M 3.31B 49.26M 330M 129M 1.66B 131M 128M 5.49B |
| Net income | -24.62M -21.3M -19.89M -18.25M -34.32M -2.34B -34.86M -233M -91.59M -1.17B -92.46M -90.43M -3.88B | -17.63M -15.25M -14.24M -13.06M -24.57M -1.68B -24.96M -167M -65.58M -841M -66.2M -64.75M -2.78B |
| Net Debt | 20.41M 17.66M 16.49M 15.13M 28.45M 1.94B 28.9M 193M 75.93M 974M 76.66M 74.98M 3.22B | 11.94M 10.33M 9.65M 8.85M 16.64M 1.14B 16.91M 113M 44.42M 570M 44.84M 43.86M 1.88B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change |
|---|---|---|
| 26-08-07 | $0.2500 | -3.85% |
| 26-08-06 | $0.2600 | -8.77% |
| 26-08-05 | $0.2850 | +3.64% |
| 26-08-04 | $0.2750 | -1.79% |
| 26-07-31 | $0.2800 | 0.00% |
- Stock Market
- Stocks
- LEEF Stock
- LEEF Stock
Select your edition
All financial news and data tailored to specific country editions
